Cancer cells being destroyed by immunotherapy.
(Source: Adobe Stock)

Discover BioVaxys’ innovative DPX™ platform, a cutting-edge lipid-based delivery system transforming immunotherapy. This video explores how the company’s proprietary technology encapsulates diverse bioactive molecules, enhancing and sustaining immune responses. Learn how BioVaxys is leveraging this groundbreaking platform to potentially revolutionize vaccines and treatments.

To keep up with the latest developments from the company, visit https://www.biovaxys.com/

This is third-party content provided by BioVaxys Technology Corp. (CSE:BIOV). Please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this company on the BioVaxys Technology Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

(Top photo: Adobe Stock)


More From The Market Online
Blocks spelling out 2025 with arrows and a percentage sign

@ the Bell: Canadian and U.S. stocks begin 2025 with a mixed bag

Canada’s TSX index ended with a solid gain on the first trading day of 2025 thanks to optimism in healthcare, energy and base metal stocks.
BlackBerry and QNX vehicle software

BlackBerry relaunches QNX software brand

BlackBerry (TSX:BB) is relaunching its QNX software brand to strengthen its position in the automotive and general embedded industries.
HIVE Digital Technologies' 32 MW facility in Boden, Sweden

This Bitcoin mining stock is ramping up operations in 2025

Bitcoin mining stock HIVE Digital Technologies (TSXV:HIVE) recently reached an operational hashrate of 6 exahashes per second.